Michael Yang

CEO, President

Michael Yang was appointed as President and Chief Executive Officer in January of 2021. Michael Yang was formerly the Chief Commercial officer of Acadia Pharmaceuticals. Prior to his nearly four years at Acadia, Yang was Janssen’s president in charge of their US immunology business, and before that, he was the J&J subsidiary’s CNS president.


Roles at ViaCyte

  • CEO, President

    January 29, 2021 - present

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at ViaCyte

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.